explore -WSS

explore

author：knowledge 2025-09-02 22:26:15 - browse：714

Boxes of Ozempic photo illustration. -- health coverage from STAT — Mario Tama/Getty Images

LONDON — Novo Nordisk’s diabetes medication Ozempic cut the risk of patients developing advanced kidney disease or dying from kidney or heart complications, the company said Tuesday, adding to the evidence the wildly popular drug has broader health benefits for patients beyond addressing their diabetes.

Overall, Ozempic lowered the risk of progression of patients’ kidney disease and of related health events by 24% versus placebo, according to the topline results. The company, which will present full data from the study later this year, said it would file for an expanded approval of Ozempic based on the data in both the U.S. and Europe.

The positive announcement had been expected since October, when Novo announced it was ending the FLOW trial early because an interim data analysis showed the drug was surpassing the study’s goals. Still, the results provide an important data point for Novo both as its medicines face increasing competition and as it tries to get more insurers to cover its related obesity drug Wegovy.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： The drug industry sees a key ally in the Senate prevail

explore

WSS

Zapping the brain for stroke rehab: Pivotal clinical trial begins

Cheesesteak restaurant owner explains his secret sauce, the viral Malibu Barbie Dream Drizzle

Sage's campaign to raise awareness of postpartum depression hits a nerve

Astronauts get first look at the spacecraft that will fly them around the moon

The drug industry sees a key ally in the Senate prevail

Dramatically reducing cancer deaths requires the PASTEUR Act

hotspot

explore

knowledge

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

For BCIs, commercial hurdles may be bigger than scientific ones

Cancer drug shortages should be causing more outrage

Biden calls for immediate release of Niger's president amid apparent coup

Heart attack and stroke risk calculators need revising

Mega Millions jackpot estimated at record $1.58 billion for Tuesday's drawing

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

The painfully weak evidence on taking collagen to treat arthritis

Moonlake's readout produced a cash windfall. Risks remain

Ohioans vote in high

explore

For BCIs, commercial hurdles may be bigger than scientific ones

In venture capital firm's success, lessons for turning crisis into profit

Biden praises World Series champion Astros for impact off the field during White House celebration

Germany receives 178 compensation applications from gay servicepeople over discrimination

Stem cell clinics for heart failure: buyer be wary

Trump attorney outlines possible Jan. 6 legal defenses, but some experts are skeptical

Wikipedia

explore

explore

hotspot